Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma
- 1 July 2004
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 72 (1) , 79-82
- https://doi.org/10.1016/j.radonc.2004.02.009
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicityInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Radiotherapy Enhanced Ototoxicity of Cisplatin in ChildrenActa Oto-Laryngologica, 1997
- Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: A prospective study of the effect of radiation and cisplatin treatmentInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Effect of irradiation on middle ear effusion due to nasopharyngeal carcinomaClinical Otolaryngology, 1992
- Cis‐Platinum ototoxicity in childrenThe Laryngoscope, 1991
- Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Platinum chemotherapy, radiotherapy and the inner ear: implications for “standard” radiation portalsThe British Journal of Radiology, 1989
- Enhanced cis‐platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiationMedical and Pediatric Oncology, 1989
- Ototoxicity of low- and moderate-dose cisplatinCancer, 1985
- Sensori‐Neural hearing loss following radiotherapy to the nasopharynxThe Laryngoscope, 1976